JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,699,000 | +5128.4% | 124,679 | +5032.9% | 0.00% | – |
| Q3 2017 | $109,000 | +319.2% | 2,429 | +169.3% | 0.00% | – |
| Q2 2017 | $26,000 | -79.8% | 902 | -84.5% | 0.00% | – |
| Q1 2017 | $129,000 | -74.8% | 5,801 | -78.6% | 0.00% | – |
| Q4 2016 | $511,000 | +192.0% | 27,101 | +367.9% | 0.00% | – |
| Q3 2016 | $175,000 | -23.6% | 5,792 | -2.5% | 0.00% | – |
| Q2 2016 | $229,000 | -4.2% | 5,942 | -5.5% | 0.00% | – |
| Q1 2016 | $239,000 | -20.9% | 6,289 | -8.4% | 0.00% | – |
| Q4 2015 | $302,000 | -63.5% | 6,867 | -66.2% | 0.00% | -100.0% |
| Q3 2015 | $827,000 | +6261.5% | 20,288 | +8015.2% | 0.00% | – |
| Q2 2015 | $13,000 | -97.8% | 250 | -97.4% | 0.00% | – |
| Q1 2015 | $585,000 | +6400.0% | 9,630 | +5402.9% | 0.00% | – |
| Q4 2014 | $9,000 | – | 175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |